Hiromichi Miyagaki

Chief

Ottawa Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiromichi Miyagaki is the Chief at Otemae Hospital in Japan. His research primarily focuses on minimally invasive surgical techniques and the oncological outcomes associated with colorectal and gastric cancers. He has contributed to several recent studies exploring the effects of various treatments and patient outcomes related to cancer surgeries.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (1)

Takahito Sugase

Osaka International Cancer Institute

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiromichi Miyagaki

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902).

Plasma levels of progranulin, a tumorigenic protein, are persistently elevated during the first month after minimally invasive colorectal cancer resection

Analysis of the risk factors for osteoporosis and its prevalence after gastrectomy for gastric cancer in older patients: a prospective study

Impact of regional lymph node metastasis on pulmonary metastasis as the first recurrence site.

Single-incision laparoscopic surgery for intestinal intussusception due to neuroendocrine tumor

Oncological outcomes following minimally invasive surgery for pathological N2M0 colorectal cancer: A propensity score-matched analysis.

A case in which the ileocolic vein draining into the gastrocolic trunk of Henle could be diagnosed preoperatively: a rare anatomical case report.

Impact of antithrombotic agents on short-term outcomes following minimally invasive colorectal cancer surgery: a propensity score-matched analysis.

Osteopontin Levels Are Persistently Elevated for 4 weeks Following Minimally Invasive Colorectal Cancer Resection.

Plasma Levels of Keratinocyte Growth Factor Are Significantly Elevated for 5 Weeks After Minimally Invasive Colorectal Resection Which May Promote Cancer Recurrence and Metastasis.

Collaborators (1)

Takahito Sugase

Make your next move.